1874 J . Org. Chem., Vol. 66, No. 5, 2001
Ohno et al.
(2C), 30.4, 33.3, 39.1, 59.1, 74.8, 76.0, 81.2, 131.8 (2C), 135.7,
138.0 (2C), 141.7; MS (FAB) m/z 366 (MH+, 100); HRMS (FAB)
calcd C20H32NO3S (MH+) 366.2103, found 366.2113.
(3S,4S,5S)-4-Eth yn yl-2-m eth yl-5-[N-(2,4,6-tr im eth ylph en -
ylsu lfon yl)a m in o]-6-p h en ylh exa n -3-ol (24). By a procedure
identical with that described for the synthesis of 15 from 3c,
4c (67.9 mg, 0.26 mmol) was converted into 24 (60.0 mg, 72%
yield): colorless oil; [R]24D -10.5 (c 1.00, CHCl3); IR (KBr) cm-1
3516 (OH), 3296 (NHSO2), 2116 (CtC), 1319 (NHSO2); 1H
NMR (300 MHz, CDCl3) δ 0.78 (d, J ) 6.9 Hz, 3H, CMe), 1.00
(d, J ) 6.6 Hz, 3H, CMe), 1.79-1.93 (m, 1H, 2-H), 2.17 (d, J
) 2.4 Hz, 1H, CtCH), 2.28 (s, 3H, Ph-Me), 2.53-2.56 (m, 1H,
OH), 2.56 (s, 6H, 2 × Ph-Me), 2.61 (ddd, J ) 7.5, 2.4, 2.4 Hz,
1H, 4-H), 2.86 (dd, J ) 14.1, 5.7 Hz, 1H, PhCHH), 3.04 (dd, J
) 14.1, 6.0 Hz, 1H, PhCHH), 3.36-3.42 (m, 1H, 3-H), 3.74-
3.84 (m, 1H, 5-H), 5.05 (d, J ) 9.3 Hz, 1H, NH), 6.87 (s, 2H,
Ph), 7.02-7.20 (m, 5H, Ph); 13C NMR (75 MHz, CDCl3) δ 18.9,
19.1, 20.8, 23.3 (2C), 32.3, 38.7, 39.9, 55.6, 74.1, 74.5, 80.8,
126.7, 128.5 (2C), 129.3 (2C), 132.0 (2C), 134.5, 136.2, 138.5
(2C), 142.0; MS (FAB) m/z 414 (MH+, 100); HRMS (FAB) calcd
C24H32NO3S (MH+) 414.2103, found 414.2101.
(3R,4R,5R)-6-ter t-Bu t yld im et h ylsilyloxy-4-et h yn yl-2-
m eth yl-5-[N-(2,4,6-tr im eth ylph en ylsu lfon yl)am in o]h exan -
3-ol (19). By a procedure identical with that described for the
synthesis of 15 from 3c, 3e (78.7 mg, 0.2 mmol) was converted
into 19 (64.0 mg, 68% yield): colorless oil; [R]27D +15.6 (c 1.43,
CHCl3); IR (KBr) cm-1 3552 (OH), 3311 (NHSO2), 2116 (Ct
C), 1335 (NHSO2); 1H NMR (270 MHz, CDCl3) δ -0.01 (s, 3H,
SiMe), 0.00 (s, 3H, SiMe), 0.76 (d, J ) 6.8 Hz, 3H, CMe), 0.84
(s, 9H, CMe3), 0.90 (d, J ) 6.8 Hz, 3H, CMe), 1.56-1.68 (m,
1H, 2-H), 2.14 (d, J ) 2.4 Hz, 1H, CtCH), 2.28-2.30 (m, 1H,
OH), 2.30 (s, 3H, Ph-Me), 2.65 (s, 6H, 2 × Ph-Me), 3.02-3.07
(m, 1H, 4-H), 3.12-3.18 (m, 1H, 3-H), 3.33-3.41 (m, 1H, 5-H),
3.51 (dd, J ) 9.7, 7.3 Hz, 1H, 6-CHH), 3.66 (dd, J ) 9.7, 3.8
Hz, 1H, 6-CHH), 5.11 (d, J ) 8.4 Hz, 1H, NH), 6.96 (s, 2H,
Ph); 13C NMR (67.8 MHz, CDCl3) δ -5.53, -5.48, 17.3, 18.2,
19.3, 21.0, 23.2 (2C), 25.8 (3C), 31.6, 37.6, 55.5, 62.8, 74.0, 75.4,
80.1, 131.9 (2C), 134.2, 138.8 (2C), 142.3; MS (FAB) m/z 468
(MH+, 100), 119 (74); HRMS (FAB) calcd C24H42NO4SSi (MH+)
468.2604, found 468.2605.
(3S,4S,5R)-6-ter t-Bu t yld im et h ylsilyloxy-4-et h yn yl-2-
m eth yl-5-[N-(2,4,6-tr im eth ylph en ylsu lfon yl)am in o]h exan -
3-ol (26). By a procedure identical with that described for the
synthesis of 15 from 3c, 4e (78.7 mg, 0.2 mmol) was converted
into 26 (65.8 mg, 70% yield): colorless oil; [R]28D -5.91 (c 0.930,
CHCl3); IR (KBr) cm-1 3541 (OH), 3311 (NHSO2), 2118 (Ct
(3R,4R,5S)-4-Eth yn yl-2-m eth yl-5-[N-(4-m eth ylp h en yl-
su lfon yl)a m in o]h exa n -3-ol (20) a n d Its (3S,4S,5S)-Isom er
(21). By a procedure identical with that described for the
synthesis of 15 from 3c, 3f (47.1 mg, 0.2 mmol) was converted
into 20 (41.1 mg, 73% yield) and 21 (3.1 mg, 6% yield).
1
C), 1326 (NHSO2); H NMR (270 MHz, CDCl3) δ 0.02 (s, 3H,
SiMe), 0.03 (s, 3H, SiMe), 0.86 (d, J ) 5.9 Hz, 3H, CMe), 0.87
(s, 9H, CMe3), 1.08 (d, J ) 6.5 Hz, 3H, CMe), 1.91-2.03 (m,
1H, 2-H), 2.08 (d, J ) 2.4 Hz, 1H, CtCH), 2.31 (s, 3H, Ph-
Me), 2.64 (s, 6H, 2 × Ph-Me), 2.74 (ddd, J ) 10.3, 2.4, 2.4 Hz,
1H, 4-H), 2.98 (dd, J ) 10.3, 3.2 Hz, 1H, 6-CHH), 3.22 (d, J )
5.9 Hz, 1H, OH), 3.24-3.36 (m, 1H, 5-H), 3.60 (ddd, J ) 9.5,
5.9, 2.4 Hz, 1H, 3-H), 3.89 (dd, J ) 10.3, 0.8 Hz, 1H, 6-CHH),
5.43 (d, J ) 9.7 Hz, 1H, NH), 6.97 (s, 2H, Ph); 13C NMR (67.8
MHz, CDCl3) δ -5.56, -5.45, 18.3, 18.9, 20.1, 21.0, 23.0 (2C),
25.8 (3C), 31.9, 37.9, 54.5, 61.7, 73.0, 73.8, 80.7, 132.0 (2C),
133.9, 138.6 (2C), 142.5; MS (FAB) m/z 468 (MH+, 100), 119
(78); HRMS (FAB) calcd C24H42NO4SSi (MH+) 468.2604, found
468.2585.
Compound 20: colorless crystals; mp 114-115 °C (EtOAc-
hexane); [R]26D -13.5 (c 1.00, CHCl3); IR (KBr) cm-1 3535 (OH),
3236 (NHSO2), 2119 (CtC), 1319 (NHSO2); 1H NMR (300
MHz, CDCl3) δ 0.84 (d, J ) 6.9 Hz, 3H, CMe), 0.91 (d, J ) 6.6
Hz, 3H, CMe), 1.18 (d, J ) 6.6 Hz, 3H, CMe), 1.67-1.78 (m,
1H, 2-H), 2.08 (d, J ) 6.6 Hz, 1H, OH), 2.22 (d, J ) 2.7 Hz,
1H, CtCH), 2.43 (s, 3H, Ph-Me), 2.58 (ddd, J ) 3.9, 3.9, 2.7
Hz, 1H, 4-H), 3.21 (ddd, J ) 6.6, 6.6, 3.9 Hz, 1H, 3-H), 3.44-
3.49 (m, 1H, 5-H), 5.08 (d, J ) 7.2 Hz, 1H, NH), 7.30-7.33
(m, 2H, Ph), 7.76-7.79 (m, 2H, Ph); 13C NMR (75 MHz, CDCl3)
δ 17.2, 19.3, 20.7, 21.5, 31.8, 42.3, 51.3, 74.7, 76.2, 79.6, 127.2
(2C), 129.6 (2C), 137.5, 143.5. MS (FAB) m/z 310 (MH+, 67),
69 (100); HRMS (FAB) calcd C16H24NO3S (MH+) 310.1477,
found 310.1479. Anal. Calcd for C16H23NO3S: C, 62.11; H, 7.49;
N, 4.53. Found: C, 61.86; H, 7.36; N, 4.50.
Compound 21: colorless crystals; mp 173 °C (EtOAc-
hexane); [R]26D -64.4 (c 0.99, CHCl3); IR (KBr) cm-1 3439 (OH),
3288 (NHSO2), 2116 (CtC), 1317 (NHSO2); 1H NMR (300
MHz, CDCl3) δ 0.86 (d, J ) 6.6 Hz, 3H, CMe), 1.02 (d, J ) 6.6
Hz, 3H, CMe), 1.10 (d, J ) 6.3 Hz, 6H, CMe), 1.81-1.93 (m,
1H, 2-H), 2.11 (d, J ) 2.4 Hz, 1H, CtCH), 2.44 (s, 3H, Ph-
Me), 2.48 (ddd, J ) 7.4, 2.4, 2.4 Hz, 1H, 4-H), 2.63 (d, J ) 6.6
Hz, 1H, OH), 3.46-3.59 (m, 2H, 3-H and 5-H), 4.59 (d, J )
9.3 Hz, 1H, NH), 7.31-7.34 (m, 2H, Ph), 7.56-7.78 (m, 2H,
Ph); 13C NMR (75 MHz, CDCl3) δ 19.0 (2C), 19.7, 21.5, 31.9,
43.1, 50.5, 73.5, 74.3, 80.6, 127.1 (2C), 129.8 (2C), 137.4, 143.7;
MS (FAB) m/z 310 (MH+, 100); HRMS (FAB) calcd C16H24NO3S
(MH+) 310.1477, found 310.1500.
(2S,3S,4S)-2-ter t-Bu tyld im eth ysilyloxy-3-eth yn yl-4-[N-
(4-m eth oxy-2,3,6-tr im eth ylph en ylsu lfon yl)am in o]-5-ph en -
ylp en ta n e (34) a n d Its (2R,3S,4S)-Isom er (35). By a
procedure identical with that described for the preparation of
15 from 3c, the aziridine 4d (73.9 mg, 0.2 mmol) was converted
into an inseparable mixture of 32 and 33 (73.9 mg, 75%; 32:
1
33 ) 88:12, H NMR) by treatment with Pd(PPh3)4 (11.6 mg,
0.01 mmol), InI (62.8 mg, 0.26 mmol), MeCHO (17 µL, 0.3
mmol) and H2O (4 µL, 0.2 mmol) in a mixed solvent of THF
(0.8 mL) and HMPA (0.2 mL). To a stirred solution of the above
diastereomixture (38 mg, 0.0914 mmol) in DMF (1 mL) were
added imidazole (15.6 mg, 0.229 mmol) and tert-butyldimeth-
ylsilyl chloride (13.4 mg, 0.11 mmol) at room temperature. The
mixture was stirred at room temperature for 48 h and was
made acidic with 0.5 N HCl. The whole was extracted with
Et2O and the extract was washed with water and dried
(MgSO4). Usual workup followed by flash chromatography over
silica gel with hexane-CHCl3-EtOAc (15:6:1) gave, in order
of elution, 34 (42.1 mg, 87% yield) and 35 (4.6 mg, 10% yield).
Compound 34: colorless needles; mp 138 °C (hexane-Et2O);
[R]18D -20.6 (c 0.96, CHCl3); IR (KBr) cm-1 3307 (NHSO2), 2114
(CtC), 1308 (NHSO2); 1H NMR (270 MHz, CDCl3) δ -0.01 (s,
3H, SiMe), 0.00 (s, 3H, SiMe), 0.79 (s, 9H, CMe3), 1.15 (d, J )
6.2 Hz, 3H, 1-Me), 2.00 (s, 3H, Ph-Me), 2.05 (d, J ) 2.4 Hz,
1H, CtCH), 2.30 (s, 3H, Ph-Me), 2.59 (s, 3H, Ph-Me), 2.61-2.64
(m, 1H, 3-H), 2.83 (dd, J ) 14.3, 7.0 Hz, 1H, 5-CHH), 2.89
(dd, J ) 14.3, 5.4 Hz, 1H, 5-CHH), 3.61-3.70 (m, 1H, 4-H),
3.78 (s, 3H, OMe), 3.92-4.00 (m, 1H, 2-H), 5.49 (d, J ) 6.8 Hz,
1H, NH), 6.45 (s, 1H, Ph), 6.89-6.93 (m, 2H, Ph), 7.03-7.05
(m, 3H, Ph); 13C NMR (67.8 MHz, CDCl3) δ -4.53, -4.22, 12.1,
18.1, 18.2, 20.9, 24.8, 25.8 (3C), 37.9, 43.5, 55.0, 55.5, 69.2,
73.1, 81.8, 111.8, 124.9, 126.2, 127.9 (2C), 129.2 (2C), 129.5,
136.8, 138.1, 139.1, 158.9. Anal. Calcd for C29H43NO4SSi: C,
65.74; H, 8.18; N, 2.64. Found: C, 65.82; H, 8.17; N, 2.67.
(3S,4S,5S)-4-Eth yn yl-2,6-d im eth yl-5-[N-(2,4,6-tr im eth -
ylp h en ylsu lfon yl)a m in o]h ep ta n -3-ol (22). By a procedure
identical with that described for the synthesis of 15 from 3c,
4a (87.4 mg, 0.3 mmol) was converted into 22 (64.7 mg, 59%
yield): colorless crystals; mp 66 °C (hexane-Et2O); [R]27D -35.1
(c 1.45, CHCl3); IR (KBr) cm-1 3537 (OH), 3302 (NHSO2), 2116
1
(CtC), 1313 (NHSO2); H NMR (270 MHz, CDCl3) δ 0.46 (d,
J ) 6.8 Hz, 3H, CMe), 0.82 (d, J ) 6.8 Hz, 3H, CMe), 0.86 (d,
J ) 6.8 Hz, 3H, CMe), 1.02 (d, J ) 6.5 Hz, 3H, CMe), 1.87-
2.01 (m, 1H, Me2CH), 2.09 (d, J ) 2.4 Hz, 1H, CtCH), 2.28-
2.35 (m, 1H, Me2CH), 2.29 (s, 3H, Ph-Me), 2.55 (d, J ) 9.5 Hz,
1H, OH), 2.64 (s, 6H, 2 × Ph-Me), 3.04-3.07 (m, 1H, 4-H),
3.34-3.40 (m, 1H, 3-H), 3.48 (ddd, J ) 10.3, 10.0, 3.0 Hz, 1H,
5-H), 4.73 (dd, J ) 10.3, 4.1 Hz, 1H, NH), 6.94 (s, 2H, Ph); 13
C
NMR (67.8 MHz, CDCl3) δ 15.8, 19.1, 19.8, 20.3, 21.0, 23.3
(2C), 29.7, 32.0, 40.5, 59.2, 73.1, 74.0, 80.8, 131.8 (2C), 135.3,
138.1 (2C), 142.0; MS (EI) m/z 367 (M + 2, 0.2), 254 (100).
Anal. Calcd for C20H31NO3S: C, 65.72; H, 8.55; N, 3.83.
Found: C, 65.44; H, 8.70; N, 3.61.
Compound 35: colorless oil; [R]21 -50.2 (c 0.235, CHCl3);
D
IR (KBr) cm-1 3307 (NHSO2), 2114 (CtC), 1308 (NHSO2); 1H
NMR (270 MHz, CDCl3) δ 0.03 (s, 3H, SiMe), 0.08 (s, 3H,